Skip to main content

Prostate

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
Doxazosin mysylate GITSPhase 41 trial
Active Trials
NCT00648323Completed80Est. Jan 2005
Boston Scientific
Boston ScientificCA - Valencia
1 program
TheraSphere PCaN/A1 trial
Active Trials
NCT06192758Active Not Recruiting36Est. Oct 2032
MTI
MTIUT - Salt Lake City
1 program
otago excercisesN/A1 trial
Active Trials
NCT06605846Completed110Est. Apr 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
PfizerDoxazosin mysylate GITS
MTIotago excercises
Boston ScientificTheraSphere PCa

Clinical Trials (3)

Total enrollment: 226 patients across 3 trials

NCT00648323PfizerDoxazosin mysylate GITS

Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement

Start: Nov 2003Est. completion: Jan 200580 patients
Phase 4Completed
NCT06605846MTIotago excercises

Otago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation Therapy

Start: Sep 2024Est. completion: Apr 2025110 patients
N/ACompleted
NCT06192758Boston ScientificTheraSphere PCa

Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

Start: Apr 2024Est. completion: Oct 203236 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.